Early research (Phase 1)Study completedNCT00117429
What this trial is testing
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20